The U.K’s National Institute for Health and Care Excellence (NICE) on Wednesday recommended Pfizer I...
Advancing care for stage 3 or 4 Hodgkin lymphoma patients...
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Lymphoma Therapeutics - Global Strategic Business Re...
Pfizer secured an eighth indication for its blood cancer drug Adcetris after the FDA approved its us...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Admin...